Clinical Trial Update: Phase 2/3 Study of TLC590 for Postsurgical Pain Management [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 study update for TLC590 in postsurgical pain management; not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postsurgical Pain Management

Drugs mentioned

• TLC590

Snippet

Sponsor: Taiwan Liposome Company | Conditions: Postsurgical Pain Management | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING